drugset / Trial / NCT03998683
A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of guselkumab for the treatment of palmoplantar psoriasis.
Timeline
- Start
- 2019-09-03
- Primary completion
- 2021-03-02
- Completion
- 2021-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guselkumab | Monoclonal antibody | 100 mg | Subcutaneous |